drugset / Trial / NCT05544513
Oral Iron Supplementation for Patients With Chronic Kidney Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription
Timeline
- Start
- 2022-08-01
- Primary completion
- 2026-12-29
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 120 mg | Oral |
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 240 mg | Oral |